AAAAAA
Results:
1-23
|
Results: 23
Authors:
Schonermarck, U
Lamprecht, P
Csernok, E
Gross, WL
Citation: U. Schonermarck et al., Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA, RHEUMATOLOG, 40(2), 2001, pp. 178-184
Authors:
Hattar, K
Sibelius, U
Bickenbach, A
Csernok, E
Seeger, W
Grimminger, F
Citation: K. Hattar et al., Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis, J LEUK BIOL, 69(1), 2001, pp. 89-97
Authors:
Rautenstrauch, J
Gause, A
Csernok, E
Holle, J
Gross, WL
Citation: J. Rautenstrauch et al., Presentation of "Kompetenzzentrum Lubeck Bad Bramstedt", Z RHEUMATOL, 60(4), 2001, pp. 255-262
Authors:
Lamprecht, P
Moosig, F
Csernok, E
Seitzer, U
Schnabel, A
Mueller, A
Gross, WL
Citation: P. Lamprecht et al., CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis, THORAX, 56(10), 2001, pp. 751-757
Authors:
Steiner, K
Moosig, F
Csernok, E
Selleng, K
Gross, WL
Fleischer, B
Broker, BM
Citation: K. Steiner et al., Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener'sgranulomatosis, CLIN EXP IM, 126(1), 2001, pp. 143-150
Authors:
Kiene, A
Csernok, E
Mulller, A
Metzler, C
Trabandt, A
Gross, WL
Citation: A. Kiene et al., Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome, ARTH RHEUM, 44(2), 2001, pp. 469-473
Authors:
Lamprecht, P
Moosig, F
Gause, A
Herlyn, K
Csernok, E
Hansen, H
Gross, WL
Citation: P. Lamprecht et al., Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis, ANN RHEUM D, 60(4), 2001, pp. 385-390
Authors:
Lamprecht, P
DeGroot, K
Schnabel, A
Csernok, E
Liedvogel, B
Gross, WL
Citation: P. Lamprecht et al., Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosis, RHEUMATOLOG, 39(5), 2000, pp. 568-570
Authors:
Schnabel, A
Csernok, E
Braun, J
Gross, WL
Citation: A. Schnabel et al., Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegener's granulomatosis, AM J R CRIT, 161(2), 2000, pp. 399-405
Authors:
Szymkowiak, CH
Csernok, E
Reinhold, D
Bank, U
Gross, WL
Kekow, J
Citation: Ch. Szymkowiak et al., Neutrophils synthesize and activate TGF beta 2, CYTOKINE, 12(4), 2000, pp. 397-400
Authors:
Schultz, H
Csernok, E
Schuster, A
Schmitz, TS
Ernst, M
Gross, WL
Citation: H. Schultz et al., Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI, PEDIAT A IM, 11(2), 2000, pp. 64-70
Authors:
Schonermarck, U
Csernok, E
Trabandt, A
Hansen, H
Gross, WL
Citation: U. Schonermarck et al., Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides, CLIN EXP RH, 18(4), 2000, pp. 457-463
Authors:
Csernok, E
Gross, WL
Citation: E. Csernok et Wl. Gross, Primary vasculitides and vasculitis confined to skin: clinical features and new pathogenic aspects, ARCH DERM R, 292(9), 2000, pp. 427-436
Authors:
Schultz, H
Csernok, E
Nikkari, S
Toivanen, P
Toivanen, A
Gross, WL
Citation: H. Schultz et al., BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI molecule, SC J RHEUM, 29(4), 2000, pp. 226-231
Authors:
Muller, A
Trabandt, A
Gloeckner-Hofmann, K
Seitzer, U
Csernok, E
Schonermarck, U
Feller, AC
Gross, WL
Citation: A. Muller et al., Localized Wegener's granulomatosis: Predominance of CD26 and IFN-gamma expression, J PATHOLOGY, 192(1), 2000, pp. 113-120
Authors:
Moosig, F
Csernok, E
Kumanovics, G
Gross, WL
Citation: F. Moosig et al., Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha), CLIN EXP IM, 122(3), 2000, pp. 499-503
Authors:
Hellmich, B
Csernok, E
Trabandt, A
Gross, WL
Ernst, M
Citation: B. Hellmich et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression ofproteinase 3 (PR3) on neutrophils in vitro, CLIN EXP IM, 120(2), 2000, pp. 392-398
Authors:
Schnabel, A
Renz, H
Petermann, R
Csernok, E
Gross, WL
Citation: A. Schnabel et al., T cell receptor V beta repertoire in bronchoalveolar lavage in Wegener's granulomatosis and sarcoidosis, INT A AL IM, 119(3), 1999, pp. 223-230
Authors:
Schnabel, A
Reuter, M
Csernok, E
Richter, C
Gross, WL
Citation: A. Schnabel et al., Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity, EUR RESP J, 14(1), 1999, pp. 118-124
Authors:
Cornely, OA
Hauschild, S
Weise, C
Csernok, E
Gross, WL
Salzberger, B
Fatkenheuer, G
Diehl, V
Schrappe, M
Citation: Oa. Cornely et al., Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection, INFECTION, 27(2), 1999, pp. 92-96
Authors:
de Groot, K
Csernok, E
Wang, G
Gross, WL
Citation: K. De Groot et al., Diagnostic value of ANCA antigen testing in primary systemic vasculitides, NIEREN HOCH, 28(7), 1999, pp. 247
Authors:
Schnabel, A
Csernok, E
Braun, J
Gross, WL
Citation: A. Schnabel et al., Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome, THORAX, 54(9), 1999, pp. 771-778
Authors:
Csernok, E
Trabandt, A
Muller, A
Wang, GCC
Moosig, F
Paulsen, J
Schnabel, A
Gross, WL
Citation: E. Csernok et al., Cytokine profiles in Wegener's granulomatosis - Predominance of type 1 (Th1) in the granulomatous inflammation, ARTH RHEUM, 42(4), 1999, pp. 742-750
Risultati:
1-23
|